Description
EXPRESS REPORT: PPV MAR FY2016 NCO 18
First action · last action
2016-03-01 · 2016-03-01
Transactions
1
First transaction's obligation
$10,361,853
Base + all options value (sum of deltas)
$10,361,853
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
5
SDVOSB flag on record
No
Parent IDV
VA797P12D0001
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2016-03-01+$10,361,853= $10,361,853
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2016-03-01 | +$10,361,853 | $10,361,853 | EXPRESS REPORT: PPV MAR FY2016 NCO 18 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI S1RUKWWRYFL6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24126F0121 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6505 · DRUGS AND BIOLOGICALS | $16,333 | FY2026 |
| 36C24226P0805 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $16,333 | FY2026 |
| 36C24026K1010 | VHA CHIEF LOGISTICS OFFICE (36C240) · 6505 · DRUGS AND BIOLOGICALS | $1,194,619,137 | FY2026 |
| 36C24026K1009 | VHA CHIEF LOGISTICS OFFICE (36C240) · 6505 · DRUGS AND BIOLOGICALS | $1,191,973,258 | FY2026 |
| 36C26226P1049 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $220,957 | FY2026 |
| 36C24026K1008 | VHA CHIEF LOGISTICS OFFICE (36C240) · 6505 · DRUGS AND BIOLOGICALS | $1,398,025,092 | FY2026 |
Other recipients under 6505 from 258-NETWORK CONTRACT OFFICE 18 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25816P0866 | MCKESSON CORPORATION | 258-NETWORK CONTRACT OFFICE 18 | $27,127 | FY2016 |
| VA25816J0835 | MDD US OPERATIONS, LLC | 258-NETWORK CONTRACT OFFICE 18 | $3,524 | FY2016 |
| VA25816P0677 | VITALANT | 258-NETWORK CONTRACT OFFICE 18 | $5,292 | FY2016 |
| VA25816P0517 | INTER CHEM TRADING CORP. | 258-NETWORK CONTRACT OFFICE 18 | $36,050 | FY2016 |
| VA25816J0532 | CSL BEHRING L.L.C. | 258-NETWORK CONTRACT OFFICE 18 | $5,086 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25816E1145_3600_VA797P12D0001_3600 · retrieved 2026-09-26.